SMAD4 and neoplasm: TGF-β, particularly when tumor-suppressive SMAD4 pathways are lost, induces myofibroblastic fibroblast (myCAF) expansion and an immunosuppressive niche that fosters tumor-cell escape and dissemination (Moo-Young et al., 2009; Principe et al., 2016).